Jaguar Health (JAGX) EBIT Growth (1y) (2015 - 2026)
Jaguar Health (JAGX) EBIT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 2,150.96% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 80.62% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 8.65% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 145.20% |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 1,386.07% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 208.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 208.08% |
| Dec 31, 2025 | -160.41% |
| Sep 30, 2025 | 0.33% |
| Jun 30, 2025 | -11.25% |
| Mar 31, 2025 | -14.68% |
| Dec 31, 2024 | -7.94% |
| Sep 30, 2024 | 17.36% |
| Jun 30, 2024 | 11.17% |
| Mar 31, 2024 | 16.56% |
| Dec 31, 2023 | -20.22% |
| Sep 30, 2023 | 11.21% |
| Jun 30, 2023 | -25.05% |
| Mar 31, 2023 | 16.24% |
| Dec 31, 2022 | 41.91% |
| Sep 30, 2022 | -3.85% |
| Jun 30, 2022 | 44.05% |
| Mar 31, 2022 | -34.09% |
| Dec 31, 2021 | -109.44% |
| Sep 30, 2021 | -77.28% |
| Jun 30, 2021 | -37.03% |